Bernhard Radlwimmer
Bernhard Radlwimmer
Verified email at
Cited by
Cited by
International network of cancer genome projects
International Cancer Genome Consortium
Nature 464 (7291), 993, 2010
DNA methylation-based classification of central nervous system tumours
D Capper, DTW Jones, M Sill, V Hovestadt, D Schrimpf, D Sturm, ...
Nature 555 (7697), 469-474, 2018
Hotspot Mutations in H3F3A and IDH1 Define Distinct Epigenetic and Biological Subgroups of Glioblastoma
D Sturm, H Witt, V Hovestadt, DA Khuong-Quang, DTW Jones, ...
Cancer cell 22 (4), 425-437, 2012
An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor
CA Opitz, UM Litzenburger, F Sahm, M Ott, I Tritschler, S Trump, ...
Nature 478 (7368), 197-203, 2011
Stem cell marker CD133 affects clinical outcome in glioma patients
F Zeppernick, R Ahmadi, B Campos, C Dictus, BM Helmke, N Becker, ...
Clinical cancer research 14 (1), 123-129, 2008
A chromosome 8 gene-cluster polymorphism with low human beta-defensin 2 gene copy number predisposes to Crohn disease of the colon
K Fellermann, DE Stange, E Schaeffeler, H Schmalzl, J Wehkamp, ...
The American Journal of Human Genetics 79 (3), 439-448, 2006
Reduced H3K27me3 and DNA hypomethylation are major drivers of gene expression in K27M mutant pediatric high-grade gliomas
S Bender, Y Tang, AM Lindroth, V Hovestadt, DTW Jones, M Kool, ...
Cancer cell 24 (5), 660-672, 2013
BRAF gene duplication constitutes a mechanism of MAPK pathway activation in low-grade astrocytomas
S Pfister, WG Janzarik, M Remke, A Ernst, W Werft, N Becker, G Toedt, ...
The Journal of clinical investigation 118 (5), 1739-1749, 2008
Atypical teratoid/rhabdoid tumors are comprised of three epigenetic subgroups with distinct enhancer landscapes
PD Johann, S Erkek, M Zapatka, K Kerl, I Buchhalter, V Hovestadt, ...
Cancer cell 29 (3), 379-393, 2016
Recurrent mutation of the ID3 gene in Burkitt lymphoma identified by integrated genome, exome and transcriptome sequencing.
J Richter, M Schlesner, S Hoffmann, M Kreuz, E Leich, B Burkhardt, ...
Nature genetics 44 (12), 2012
BCAT1 promotes cell proliferation through amino acid catabolism in gliomas carrying wild-type IDH1
M Tönjes, S Barbus, YJ Park, W Wang, M Schlotter, AM Lindroth, ...
Nature medicine 19 (7), 901-908, 2013
Decoding the regulatory landscape of medulloblastoma using DNA methylation sequencing
V Hovestadt, DTW Jones, S Picelli, W Wang, M Kool, PA Northcott, ...
Nature 510 (7506), 537-541, 2014
Outcome Prediction in Pediatric Medulloblastoma Based on DNA Copy-Number Aberrations of Chromosomes 6q and 17q and the MYC and MYCN Loci
S Pfister, M Remke, A Benner, F Mendrzyk, G Toedt, J Felsberg, ...
Journal of clinical oncology 27 (10), 1627-1636, 2009
Differentiation therapy exerts antitumor effects on stem-like glioma cells
B Campos, F Wan, M Farhadi, A Ernst, F Zeppernick, KE Tagscherer, ...
Clinical Cancer Research 16 (10), 2715-2728, 2010
Longitudinal molecular trajectories of diffuse glioma in adults
FP Barthel, KC Johnson, FS Varn, AD Moskalik, G Tanner, E Kocakavuk, ...
Nature 576 (7785), 112-120, 2019
Molecular classification of diffuse cerebral WHO grade II/III gliomas using genome-and transcriptome-wide profiling improves stratification of prognostically distinct patient …
M Weller, RG Weber, E Willscher, V Riehmer, B Hentschel, M Kreuz, ...
Acta neuropathologica 129 (5), 679-693, 2015
Automated array-based genomic profiling in chronic lymphocytic leukemia: development of a clinical tool and discovery of recurrent genomic alterations
C Schwaenen, M Nessling, S Wessendorf, T Salvi, G Wrobel, ...
Proceedings of the National Academy of Sciences 101 (4), 1039-1044, 2004
BCAT1 restricts αKG levels in AML stem cells leading to IDHmut-like DNA hypermethylation
S Raffel, M Falcone, N Kneisel, J Hansson, W Wang, C Lutz, L Bullinger, ...
Nature 551 (7680), 384-388, 2017
MYC high level gene amplification is a distinctive feature of angiosarcomas after irradiation or chronic lymphedema
J Manner, B Radlwimmer, P Hohenberger, K Mössinger, S Küffer, ...
The American journal of pathology 176 (1), 34-39, 2010
Genomic and protein expression profiling identifies CDK6 as novel independent prognostic marker in medulloblastoma
F Mendrzyk, B Radlwimmer, S Joos, F Kokocinski, A Benner, DE Stange, ...
Journal of Clinical Oncology 23 (34), 8853-8862, 2005
The system can't perform the operation now. Try again later.
Articles 1–20